Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 14.399% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
(a) CCOc1ccc2nc(N(CCN(C)C)C(=O)/C=C/c3cccs3)sc2c1.Cl
(b) CCC(C(=O)NCCN1CCOCC1)n1nc(C)n2c(cc3sccc32)c1=O
(c) COc1ccc(/C=N/OCC(=O)N2CCCC2)c(OC)c1
(d) O=C(CSc1n[nH]c(-c2ccccc2F)n1)NCC(=O)Nc1ccc(F)c(F)c1F
(e) CN1CCC2(CC1)N=C(c1ccc(F)cc1)C(=S)N2C(=O)c1ccccc1
Answer: b. CCC(C(=O)NCCN1CCOCC1)n1nc(C)n2c(cc3sccc32)c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C(=O)NCCN1CCOCC1)n1nc(C)n2c(cc3sccc32)c1=O
CCC(C(=O)NCCN1CCOCC1)n1nc(C)n2c(cc3sccc32)c1=O
2-(12-methyl-9-oxo-5-thia-1,10,11-triazatricyclo[6.4.0.02,6]dodeca-2(6),3,7,11-tetraen-10-yl)-N-(2-morpholin-4-ylethyl)butanamide